| 2023 | | Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 | 공태욱 |
| 2024 | | Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer | 공태욱, 손주혁 |
| 2019 | | Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement | 공태욱 |
| 2016 | | Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO) | 장석준 |
| 2018 | | Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement | 장석준 |
| 2017 | | Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement | 백지흠 |
| 2013 | | Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. | 유희석, 이용희, 장석준 |
| 2013 | | Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases. | 유희석, 장석준, 전미선 |
| 2022 | | Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01) | 장석준 |
| 2020 | | Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study | 장석준 |
| 2021 | | Rectosigmoid resection by gynecologic oncologists versus colorectal surgeons: As long as it catches the mouse, does the color of the cat matter? | 장석준 |
| 2016 | | Risk factor analysis for massive lymphatic ascites after laparoscopic retroperitonal lymphadenectomy in gynecologic cancers and treatment using intranodal lymphangiography with glue embolization | 공태욱, 김진우, 백지흠, 원제환, 유희석, 장석준 |
| 2015 | | Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria. | 공태욱, 백지흠, 유희석, 이용희, 장석준, 전미선 |
| 2018 | | Robotic lower pelvic port placement for optimal upper paraaortic lymph node dissection | 백지흠 |
| 2011 | | Robotic single-port transumbilical total hysterectomy: a pilot study. | 백지흠 |
| 2015 | | Role of aggressive surgical cytoreduction in advanced ovarian cancer. | 장석준 |
| 2022 | | Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model | 장석준 |
| 2020 | | Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
| 2008 | | Should we modify the current FIGO staging system for stage IIIC ovarian cancer? | 유희석 |
| 2008 | | Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer | 김우영, 유승철, 유희석, 윤종혁, 장기홍, 장석준 |
| 2019 | | Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study | 백지흠 |
| 2017 | | Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy | 장석준 |
| 2017 | | Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers | 장석준 |
| 2015 | | Surgical technique of en bloc pelvic resection for advanced ovarian cancer. | 장석준 |
| 2019 | | Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study | 유희석, 장석준 |
| 2010 | | The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma. | 유희석, 장기홍, 장석준, 한재호 |
